CHARLES ROSE, MD
Internal Medicine Physician in BLOOMINGTON, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CHARLES ROSE, MD reported a CMS MIPS final score of 18.0527/100 — below the 83.1 national average — and filed 11,261 Medicare Part D claims in 2023.
- 18.0527/100
- MIPS score · -65 vs avg
- 11K
- Part D claims, 2023
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CHARLES ROSE, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
18 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
CHARLES ROSE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CHARLES ROSE, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Internal Medicine Physician compares to other specialties among Indiana providers
Internal Medicine Physician share within Indiana
Internal Medicine Physician is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHARLES ROSE, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 18.0527/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) — 18.0527/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Internal Medicine Physician US NPIs
18.0527/100 MIPS final score — 65.0 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 0. Cost dim: 60.1757.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHARLES ROSE, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 2205 W SUDBURY DR, BLOOMINGTON, IN, 47403, with a listed phone of (812) 961-1540. NPI 1477544153 was issued on 11/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROSE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 11,261 prescription claims written by this provider, covering 484 Medicare beneficiaries and totaling roughly $981K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 7.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 18.0527/100 for the 2023 performance year (Quality 0, Cost 60.1757), compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477544153 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/02/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHARLES ROSE, MD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 11,261 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 24,865
- Total Day Supply
- 724,202
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $763K
- Generic Drug Cost
- $213K
- Opioid Claims
- 829 (7.4% rate)
- Antibiotic Claims
- 309
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 0.96
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 29, 65-74: 219, 75-84: 154, 85+: 82
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CHARLES ROSE, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
716 claims
- Levothyroxine Sodium
Levothyroxine Sodium
450 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
426 claims
- Atorvastatin Calcium
Atorvastatin Calcium
364 claims
- Gabapentin
Gabapentin
309 claims
- Alprazolam 276
Alprazolam
276 claims
- Doxazosin Mesylate 263
Doxazosin Mesylate
263 claims
- Losartan Potassium 228
Losartan Potassium
228 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 716 |
| Levothyroxine Sodium | 450 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 426 |
| Atorvastatin Calcium | 364 |
| Gabapentin | 309 |
| Alprazolam | 276 |
| Doxazosin Mesylate | 263 |
| Losartan Potassium | 228 |
| Valsartan | 226 |
| Hydrochlorothiazide | 220 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How CHARLES ROSE, MD fits within the Internal Medicine Physician landscape nationally.
CHARLES ROSE, MD's 11,261 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as ROSE.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is CHARLES ROSE, MD's specialty? ▼
How much does CHARLES ROSE, MD prescribe under Medicare Part D? ▼
What is CHARLES ROSE, MD's Medicare quality score? ▼
Where is CHARLES ROSE, MD located? ▼
What is CHARLES ROSE, MD's NPI number? ▼
Does CHARLES ROSE, MD prescribe more brand-name or generic drugs? ▼
Does CHARLES ROSE, MD prescribe opioids? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does CHARLES ROSE, MD prescribe most often? ▼
Does CHARLES ROSE, MD accept Medicare? ▼
How can I verify CHARLES ROSE, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology